Upgrade to SI Premium - Free Trial

Jazz Pharmaceuticals (JAZZ) PT Raised to $337 at UBS on GEA Approval for Ziihera

September 11, 2026 8:46 AM
(Updated - September 11, 2026 9:06 AM EDT)

UBS analyst Ashwani Verma raised the price target on Jazz Pharmaceuticals ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change